Abstract
Flow cytometric studies of T-lymphocytes in breast cancer patients show that the number of cells bearing ferritin on their surface is significantly greater than normal. The number of ferritin-bearing T-cells does not appear to be related to the clinical stage of the disease nor to the serum ferritin concentration, though this is higher in cancer patients than in normal women. There is no difference in the number of T-cells positive for interleukin 2 or transferrin receptors nor in the absolute number of T-cells, T-helper cells and B-cells between normal women and those with breast cancer or benign breast disease. However, there is a significant increase in the level of HLA DR-positive T-cells and T-suppressor cells in breast cancer patients. While the significance of ferritin-bearing T-cells is not known an increase in their number appears to be associated with cancer.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Pattanapanyasat, K., Hoy, T., Jacobs, A. et al. Ferritin-bearing T-lymphocytes and serum ferritin in patients with breast cancer. Br J Cancer 57, 193–197 (1988). https://doi.org/10.1038/bjc.1988.41
Issue Date:
DOI: https://doi.org/10.1038/bjc.1988.41
This article is cited by
-
The role of iron and iron binding proteins in lymphocyte physiology and pathology
Journal of Clinical Immunology (1993)